Yuyu Pharma, Inc.
Symbol: 000225.KS
KSC
4985
KRWMarktpreis heute
-11.8661
P/E-Verhältnis
-0.1679
PEG-Verhältnis
76.98B
MRK Kapital
- 0.00%
DIV Rendite
Yuyu Pharma, Inc. (000225-KS) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 30604.9 | 30777.6 | 50263.5 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 1749.3 | 4939.1 | -2909.2 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 24454.5 | 25308.8 | 22905.2 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 44152.2 | 39832 | 25225.3 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 2384.9 | 439.3 | 494 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 101596.5 | 96357.7 | 98887.9 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 81402.7 | 81371.3 | 80341.4 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 503.2 | 50.8 | 50.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 3764.5 | 3666.5 | 4087.1 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 4267.7 | 3717.3 | 4137.9 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 10815.2 | 1004.7 | 8945 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 3764.5 | -1004.7 | -8945 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | -3633.1 | 13758.7 | 9618.1 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 96617 | 98847.3 | 94097.4 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 198213.5 | 195205.1 | 192985.3 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 10951.8 | 15840.5 | 8982.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 25386.2 | 37425 | 10427.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 574.8 | 515.4 | 1004.5 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 13640 | 1851.4 | 28739.1 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 380.9 | 0 | 2649.5 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 12247.1 | 10366.1 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 27882.7 | 7515.5 | 34285.5 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 380.9 | 793.8 | 697.8 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 77857.9 | 71831 | 64300.2 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 2592.5 | 2592.5 | 2592.5 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 17609.2 | 17609.2 | 17609.2 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 13946.5 | 31395.9 | 36540.4 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 25885.4 | 23796 | 24242.5 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 52154.1 | 41422.7 | 43296.7 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 112187.6 | 116816.2 | 124281.2 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 198213.5 | 195205.1 | 192985.3 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 8168 | 6557.8 | 4403.9 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 120355.7 | 123374 | 128685.1 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 10815.2 | 5943.8 | 6035.9 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 39407.2 | 39276.4 | 39166.5 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | 8802.3 | 13437.8 | -11097 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -7180.9 | -4425.4 | -920.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 5607.3 | 5027.4 | 4503 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 2698.8 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | -42.4 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -6772.5 | -13150.7 | -3703.6 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | 918.9 | -1760.7 | -3016.3 | |||||||||||||||||
cash-flows.row.inventory | 0 | -3424.1 | -15133.5 | -1366.8 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -5527.3 | 7090.7 | 3715.8 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 1260 | -3347.2 | -3036.3 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 9185.2 | 6319.7 | 1973.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -5106.2 | -5567.7 | -6750.9 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -770.9 | 4.6 | 1029 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -606 | -3833.6 | -822.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 3047.3 | 506 | 701.6 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -346.4 | 346.9 | -47 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -3782.2 | -8543.8 | -5889.6 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -10449.7 | -6253.3 | -906.8 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -1785.2 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2001.7 | -2033.7 | -1851.2 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 20160.8 | 989.1 | 34071 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 7709.4 | -9083.2 | 31313 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -568.9 | 8.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4766.3 | -24424.9 | 29940.6 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 30604.9 | 25838.6 | 50263.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 25838.6 | 50263.5 | 20322.8 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 839.1 | -6229 | 4508.7 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -5106.2 | -5567.7 | -6750.9 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -4267.1 | -11796.7 | -2242.2 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 137209.6 | 138881.1 | 115655.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 90704.5 | 85567.9 | 70320.1 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | 46505.1 | 53313.1 | 45335.4 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | -219.2 | 25291.4 | 23750.8 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 47254.1 | 53905.3 | 44135.2 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 137958.5 | 139473.2 | 114455.3 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 896.7 | 561.7 | 201 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 2553.8 | 2580.7 | 2175.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -4199.5 | -4502.1 | -3036.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -219.2 | 25291.4 | 23750.8 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -4199.5 | -4502.1 | -3036.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 2553.8 | 2580.7 | 2175.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 5607.3 | 5027.4 | 4503 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | -748.9 | 691.7 | 2653.5 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -4948.5 | -3810.4 | -383.2 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 98.4 | 615 | 537.1 | |||||||||||||||||
income-statement-row.row.net-income | 0 | -7180.9 | -4425.4 | -920.3 |
Häufig gestellte Frage
Wie hoch ist die Yuyu Pharma, Inc. (000225.KS) Gesamtvermögen?
Yuyu Pharma, Inc. (000225.KS) Gesamtvermögen ist 198213526767.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.352.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -285.886.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.050.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -0.001.
Was ist der Yuyu Pharma, Inc. (000225.KS) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -7180899668.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 39407153086.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 47254050269.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.